Renaissance Technologies - GRITSTONE ONCOLOGY INC ownership

GRITSTONE ONCOLOGY INC's ticker is GRTS and the CUSIP is 39868T105. A total of 101 filers reported holding GRITSTONE ONCOLOGY INC in Q1 2021. The put-call ratio across all filers is 0.47 and the average weighting 0.2%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of GRITSTONE ONCOLOGY INC
ValueSharesWeighting
Q3 2022$204,000
-83.3%
79,500
-84.3%
0.00%
-100.0%
Q2 2022$1,222,000
+19.9%
504,873
+352.5%
0.00%0.0%
Q2 2021$1,019,000
+2.6%
111,572
-55.7%
0.00%0.0%
Q4 2020$993,000
+11.4%
251,982
-25.1%
0.00%0.0%
Q3 2020$891,000
-3.2%
336,400
+142.8%
0.00%0.0%
Q2 2020$920,000
+219.4%
138,573
+179.9%
0.00%
Q1 2020$288,00049,5000.00%
Other shareholders
GRITSTONE ONCOLOGY INC shareholders Q1 2021
NameSharesValueWeighting ↓
Versant Venture Management, LLC 4,450,638$17,536,0001.82%
EcoR1 Capital, LLC 3,421,287$13,480,0000.72%
FRAZIER MANAGEMENT LLC 2,061,758$8,123,0000.63%
BVF INC/IL 2,695,418$10,620,0000.42%
Column Group LLC 869,493$3,426,0000.31%
Avidity Partners Management LP 2,122,064$8,361,0000.27%
Redmile Group, LLC 3,059,794$12,056,0000.15%
SkyOak Wealth, LLC 69,778$275,0000.09%
Tekla Capital Management LLC 419,005$1,651,0000.06%
Blackstone Inc. 2,567,445$10,116,0000.04%
View complete list of GRITSTONE ONCOLOGY INC shareholders